1. An insulin preparation containing: - an insulin compound, - a nicotine and arginine compound. 2. The insulin preparation according to claim 1, wherein the insulin compound is human insulin or an insulin analogue. The insulin preparation according to claim 1, wherein the insulin compound is selected from the group consisting of human insulin B28Asp, human insulin B3LysB29Glu and B28LysB29Pro. 4. The insulin preparation according to claim 1, wherein the insulin compound is human insulin B28Asp.5. The insulin preparation according to claim 1, wherein the insulin compound is present in an amount of from about 0.2 mM to about 2.0 mM. The insulin preparation according to claim 1, wherein the insulin compound is present in an amount of from about 0.6 mM to about 1.2 mM. The insulin preparation according to claim 1, wherein the nicotine compound is selected from the group consisting of nicotinamide, nicotinic acid, niacin, niacinamide and vitamin B3 and / or their salts and / or any combination thereof. The insulin preparation according to claim 1, wherein the nicotine compound is nicotinamide. An insulin preparation according to claim 1, comprising from about 1 mM to about 250 mM nicotine compounds. An insulin preparation according to claim 1, containing from about 1 mM to about 250 mM nicotine compounds. An insulin preparation according to claim 1, comprising from about 80 mM to about 230 mM nicotine compounds. An insulin preparation according to claim 1, comprising from about 10 mM to about 60 mM arginine. An insulin preparation according to claim 1, comprising from about 10 mM to about 30 mM arginine. An insulin preparation according to claim 1, containing about 20 mM arginine. An insulin preparation according to claim 1, which further comprises one or more buffering agents. The insulin preparation according to claim 15, wherein said buffering agent is phosphate buffering1. Препарат инсулина, содержащий:- соединение инсулина,- соединение никотина и- аргинин.2. Препар
